Divalproex News
Sun Pharma Gets USFDA Tentative Approval for Generic Depakote Delayed Release Tablets
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) for generic Depakote ®, divalproex sodium delayed release tablets.
Sun Pharma in poor health
At 1:28 pm, Sun Pharmaceutical Industries was quoting at Rs 1,095, down Rs 28.6, or 2.55%. It has touched an intraday high of Rs 1,098 and an intraday low of Rs 1,074.75.
Adults over 60 Needed for Bipolar Disorder Study
Adults over the age of 60 who experience symptoms such as mood swings, elevated or “high” mood, irritability or agitation, decreased sleep, racing thoughts, poor concentration, fast speech, risky behavior, restlessness, increased...
New Analysis Highlights Potential Of SEROQUEL For Long-term Treatment Of Bipolar Disorder
Results from a new analysis of two major clinical trials have shown that patients with bipolar disorder who received long-term treatment with SEROQUEL (quetiapine fumarate) plus a mood stabiliser were significantly less likely to...
Sandoz, Zydus sued over epilepsy drug
Abbott Laboratories sued Novartis AG's Sandoz and Cadila Healthcare Ltd.'s Zydus to prevent them from selling generic versions of the epilepsy drug Depakote ER in the U.S.